Učitavanje...
mTOR inhibitor INK128 promotes wound healing by regulating MDSCs
BACKGROUND: Skin wounds in diabetic patients hardly recover. Accumulating evidence has shown that mammalian target of rapamycin (mTOR) pathway and myeloid-derived suppressor cells (MDSCs) are involved in inflammatory-related response. INK128 is a novel mTOR kinase inhibitor in clinical development....
Spremljeno u:
| Izdano u: | Stem Cell Res Ther |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7944919/ https://ncbi.nlm.nih.gov/pubmed/33691762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-021-02206-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|